Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-05-15FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for LUNESTA (eszopiclone) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2014-05-13FDA Approved: LORAZEPAM — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for lorazepam by Hospira, Inc.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: The Effectiveness of Regular Exercise on Improving Sleep in Older Adults [Phase 2, Phase 3]
Phase 2/3 trial results indicate that regular exercise improves sleep in older adults. The study has completed and results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Efficacy of Behavioral Insomnia Treatment for Chronic Migraine [NA]
The clinical trial has completed evaluating a behavioral insomnia treatment for individuals with chronic migraine and insomnia.
-
FDA approval · 2014-04-15FDA Approved: ESZOPICLONE — Original Application (Glenmark Pharmaceuticals Inc. USA)
FDA approved eszopiclone from Glenmark as an original generic application, enabling a generic version of the insomnia medication to enter th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-04-15FDA Approved: ESZOPICLONE — Original Application (Dr. Reddy's Laboratories Limited)
Generic approval of eszopiclone by Dr. Reddy's Laboratories Limited for treatment of insomnia.
-
FDA approval · 2014-04-04FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for LUNESTA (eszopiclone) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients [Phase 3]
Phase 3 trial evaluating KI1001 for insomnia in adults age 55 and older has completed, with an update on efficacy and safety findings.
-
FDA approval · 2014-03-12FDA Approved: ZALEPLON — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for Zaleplon from Unichem Pharmaceuticals (USA), Inc., resulting in updated labeling.
-
FDA approval · 2014-03-11FDA Approved: ZALEPLON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Zaleplon from Rising Pharma Holdings, Inc., authorizing the generic zaleplon product.
-
FDA approval · 2014-03-11FDA Approved: ZALEPLON — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for zaleplon filed by Bionpharma Inc., enabling continued marketing of the generic sleep medicat…
-
FDA label_change · 2014-03-11FDA Approved: ZALEPLON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Zaleplon from Hikma Pharmaceuticals USA Inc., typically affecting the product labeling.
-
CLINICAL_TRIALS research · 2014-02-04Clinical Trial Update: To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.
A completed clinical trial examined how prevalent insomnia is among geriatric patients with chronic obstructive pulmonary disease who partic…
-
FDA approval · 2014-02-03FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for LUNESTA (eszopiclone) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2014-01-21FDA Approved: HALCION — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for Halcion (triazolam) from Pharmacia & Upjohn Company LLC.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Effects of Acupuncture and Intradermal Acupuncture on Insomnia [NA]
A clinical trial update exploring the effects of acupuncture and intradermal acupuncture on insomnia, sponsored by Kyunghee University; the …
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Acupuncture for Persistent Insomnia Associated With Major Depressive Disorder [NA]
The clinical trial update indicates that the acupuncture study for persistent insomnia associated with major depressive disorder has complet…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Insomnia and Drug Relapse Risk [Phase 3]
Phase 3 trial results update assessing the link between insomnia and relapse risk in patients with opioid use disorder. Results have been po…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Sleep and Pain Interventions in Fibromyalgia [NA]
A clinical trial investigating sleep and pain interventions in Fibromyalgia has completed. The study involved participants with Fibromyalgia…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Sleep Disorders and Their Cardiovascular Correlates in Atahualpa. [NA]
A completed clinical trial investigating sleep disorders—insomnia, hypersomnia, and sleep-disordered breathing—and their cardiovascular asso…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Acupuncture for Pain and Sleep Disturbance in Knee Osteoarthritis [NA]
This update indicates a completed clinical trial evaluating acupuncture to relieve pain and improve sleep in knee osteoarthritis.
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults [Phase 1]
Phase 1 study comparing Tai Chi training to a low-stress physical activity to enhance sleep in older adults has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: Sleep Loss and Mechanisms of Impaired Glucose Metabolism [NA]
A completed Brigham and Women's Hospital clinical trial evaluated how sleep loss affects glucose metabolism in primary insomnia, with result…
-
FDA label_change · 2013-09-18FDA Approved: ZOLPIDEM — Supplemental Application (ACI Healthcare USA, Inc)
The FDA approved a supplemental application for Zolpidem tartrate, indicating changes to the labeling for Zolpidem.
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Combined Behavioral/Pharmacological Therapy for Insomnia [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating a combined behavioral and pharmacological therapy for insomnia.